Results 271 to 280 of about 128,493 (313)
Biological aging, left ventricular dysfunction and mortality in patients with heart failure with preserved ejection fraction. [PDF]
Xu X +11 more
europepmc +1 more source
Contemporary and Emerging Therapies in the Management of Refractory Angina: A Clinical Review
ABSTRACT Refractory angina (RA) represents a growing challenge in clinical cardiology, particularly in patients with obstructive coronary artery disease (CAD) who remain symptomatic despite optimal medical therapy and who are not candidates for revascularization.
Alex Angers‐Goulet +4 more
wiley +1 more source
Early Changes in Cardiac Macrophage Subsets in Heart Failure with Preserved Ejection Fraction. [PDF]
Gutiérrez D +12 more
europepmc +1 more source
Atherectomy With Multimodal Embolic Protection for Severely Calcified Femoropopliteal Lesions
ABSTRACT Severe calcification in femoropopliteal lesions remains a clinical challenge to achieve both the technical and long‐term success in endovascular therapy. Although atherectomy is an effective treatment for calcified lesions, it is associated with the risk of distal embolization, even with the use of embolic protection devices (EPDs), and ...
Daichi Yoshii +3 more
wiley +1 more source
Metabolic dysfunction-associated steatotic liver disease and heart failure with preserved ejection fraction: A state-of-the-art review. [PDF]
Brar AS +8 more
europepmc +1 more source
ABSTRACT Background International robotic‐assisted PCI platforms such as CorPath 200 and CorPath GRX have demonstrated procedural safety and efficacy but are limited by the absence of real‐time tactile feedback and cumbersome device exchange. The ETcath200, the first domestically developed robotic PCI system in China, introduces guidewire force‐sensing
Jing Yang +8 more
wiley +1 more source
Tailoring Management of Heart Failure With Preserved Ejection Fraction Through Sex-Specific Insights. [PDF]
Kim HL.
europepmc +1 more source

